Centric Health Corp. (TSE:CRX – Free Report) – Investment analysts at Bloom Burton cut their Q4 2024 EPS estimates for Centric Health in a report issued on Monday, November 11th. Bloom Burton analyst D. Martin now anticipates that the company will earn $0.00 per share for the quarter, down from their previous estimate of $0.02. Bloom Burton also issued estimates for Centric Health’s FY2025 earnings at $0.09 EPS and FY2026 earnings at $0.20 EPS.
CRX has been the subject of several other research reports. Stifel Canada lowered Centric Health from a “strong-buy” rating to a “hold” rating in a report on Monday, August 12th. Ventum Cap Mkts upgraded shares of Centric Health to a “strong-buy” rating in a research report on Thursday, August 8th.
Centric Health Price Performance
Featured Articles
- Five stocks we like better than Centric Health
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Conference Calls and Individual Investors
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- 3 REITs to Buy and Hold for the Long Term
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
